These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 19246949)
21. Aggressiveness of cancer-care near the end-of-life in Korea. Keam B; Oh DY; Lee SH; Kim DW; Kim MR; Im SA; Kim TY; Bang YJ; Heo DS Jpn J Clin Oncol; 2008 May; 38(5):381-6. PubMed ID: 18411260 [TBL] [Abstract][Full Text] [Related]
22. The role of surgery in breast cancer patients with isolated bone metastases at the time of diagnosis. Turanli S J Surg Oncol; 2009 Aug; 100(2):95-9. PubMed ID: 19384913 [TBL] [Abstract][Full Text] [Related]
23. Colorectal cancer metastatic to the brain: time trends in presentation and outcome. Nieder C; Pawinski A; Balteskard L Oncology; 2009; 76(5):369-74. PubMed ID: 19321946 [TBL] [Abstract][Full Text] [Related]
24. Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis. Tuthill M; Pell R; Guiliani R; Lim A; Gudi M; Contractor KB; Lewis JS; Coombes RC; Stebbing J Eur J Cancer; 2009 Aug; 45(12):2146-9. PubMed ID: 19464163 [TBL] [Abstract][Full Text] [Related]
25. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884 [TBL] [Abstract][Full Text] [Related]
26. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911 [TBL] [Abstract][Full Text] [Related]
27. Biological profile of oestrogen receptor positive primary breast cancers in the elderly and response to primary endocrine therapy. Okunade G; Green AR; Ying M; Agrawal A; Paish EC; Aleskandrany M; Winterbottom L; Hassell K; Morgan DA; Ellis IO; Cheung KL Crit Rev Oncol Hematol; 2009 Oct; 72(1):76-82. PubMed ID: 19515574 [TBL] [Abstract][Full Text] [Related]
28. Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163. Ellard SL; Clemons M; Gelmon KA; Norris B; Kennecke H; Chia S; Pritchard K; Eisen A; Vandenberg T; Taylor M; Sauerbrei E; Mishaeli M; Huntsman D; Walsh W; Olivo M; McIntosh L; Seymour L J Clin Oncol; 2009 Sep; 27(27):4536-41. PubMed ID: 19687332 [TBL] [Abstract][Full Text] [Related]
29. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443 [TBL] [Abstract][Full Text] [Related]
30. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy. Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892 [TBL] [Abstract][Full Text] [Related]
31. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study. Li J; Chen P; Dai CH; Li XQ; Bao QL Geriatr Gerontol Int; 2009 Jun; 9(2):172-82. PubMed ID: 19740361 [TBL] [Abstract][Full Text] [Related]
32. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer. Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193 [TBL] [Abstract][Full Text] [Related]
34. Outcome of locally recurrent and metastatic angiosarcoma. Lahat G; Dhuka AR; Lahat S; Smith KD; Pollock RE; Hunt KK; Ravi V; Lazar AJ; Lev D Ann Surg Oncol; 2009 Sep; 16(9):2502-9. PubMed ID: 19551444 [TBL] [Abstract][Full Text] [Related]
35. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675 [TBL] [Abstract][Full Text] [Related]
36. Metastatic patterns at autopsy in patients with ovarian carcinoma. Güth U; Huang DJ; Bauer G; Stieger M; Wight E; Singer G Cancer; 2007 Sep; 110(6):1272-80. PubMed ID: 17634950 [TBL] [Abstract][Full Text] [Related]
37. Noncompliance with palliative systemic therapy in patients with distant metastatic breast cancer: a blind spot for oncologists? Elfgen C; Montagna G; Schmid SM; Bierbauer W; Güth U Breast Cancer Res Treat; 2019 Jul; 176(2):469-476. PubMed ID: 31049829 [TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy and hormonal therapy for older adults with breast cancer. Hurria A Semin Oncol; 2008 Dec; 35(6):618-24. PubMed ID: 19027465 [TBL] [Abstract][Full Text] [Related]
39. Immunotherapy prolongs the serum CEA-TPA-CA15.3 lead time at the metastatic progression in endocrine-dependent breast cancer patients: a retrospective longitudinal study. Nicolini A; Carpi A; Ferrari P; Rossi G Cancer Lett; 2008 May; 263(1):122-9. PubMed ID: 18241981 [TBL] [Abstract][Full Text] [Related]
40. Integrating epothilones into the treatment of patients with metastatic breast cancer: clinical perspectives on incorporating recent data in the practice setting. Cigler T; Vahdat L Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S166-70. PubMed ID: 19158037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]